International Journal of Pharmaceutical Compounding

Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women

Author(s): Mason Dave

Issue: Jul/Aug 2002 - Compounding for BHRT and Legal and Regulatory Issues

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2002 Pg. 255-256	Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women Author(s): Mason Dave
Mar/Apr 2005 Pg. 152	Isosorbide Dinitrate 0.1% Topical Spray Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 407	Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 64-68	Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit Author(s): Lardinois Benjamin, Dimitriou Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence M
Jan/Feb 2021 Pg. 18-23	Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol Author(s): McKettrick Greg, Yoch Doug
Jul/Aug 2023 Pg. 319	Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream Author(s): Allen Loyd V Jr
Jul/Aug 2002 Pg. 298	Estriol 2-mg/mL, Estrone 0.25-mg/mL, and Estradiol 0.25-mg/mL Topical Solution Author(s): Allen Loyd V Jr
Jul/Aug 2003 Pg. 266-270	Sensitization Therapy for Warts Author(s): Kuntz Rachael
May/Jun 2004 Pg. 231-235	Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction. Author(s): Trissel Lawrence A, Zhang Yanping
Mar/Apr 2007 Pg. 122-124	Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes Author(s): Fields Shannon W
Nov/Dec 2012 Pg. 500	Aminophylline 25-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 16-21	Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1 Author(s): Cutter Christopher B
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
May/Jun 2003 Pg. 170-174	Five Compounds for Treating Diabetes-Related Conditions Author(s): Meece Jerry
May/Jun 2022 Pg. 255-263	Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Author(s): Liew Kai Bin, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam
Sep/Oct 2003 Pg. 330-338	A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2 Author(s): Gillson George R, Zava David T
Mar/Apr 2004 Pg. 96-99	Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2 Author(s): Cutter Christopher B
May/Jun 2004 Pg. 185	Scopolamine Hydrobromide 0.25-mg/0.1-mL Topical Gel Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2003 Pg. 431	Mupirocin 0.5%, Betamethasone 0.025%, Nystatin 25,000-U/g and Clotrimazole 0.25% Nipple Ointment Author(s): Albright Lisa M
Jul/Aug 2002 Pg. 294	Dehydroepiandrosterone 25-mg/0.25-mL Sublingual Drops Author(s): Allen Loyd V Jr

Abstract

Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women

Page(s): 255-256

Abstract

Related Keywords

Related Categories

Related Articles from IJPC